Homocysteine 75 μmol/L is considered moderate hyperhomocysteinemia, and the severity varies according to individual differences and comorbid diseases. Simple hyperhomocysteinemia is generally not a serious critical condition; if combined with coronary heart disease, peripheral vascular disease and other diseases, it will increase the risk of thromboembolism and myocardial infarction.
In general, simple hyperhomocysteinemia is not a serious critical condition and can be treated with folic acid and vitamin B6 supplementation. If hyperhomocysteinemia is combined with coronary heart disease and peripheral vascular disease, it will increase the possibility of thromboembolism, stroke, and myocardial infarction, so it needs to be paid attention to, and intervention should be made in time and as early as possible, and risk factors such as hyperlipidemia and hyperglycemia should be controlled.
The normal value of homocysteine is 5-15 μmol/L, homocysteine 75 μmol/L belongs to the moderate elevation, and the incidence of hypertension, coronary heart disease and other adverse cardiovascular events in patients with hyperhomocysteinemia in general is 2-3 times higher than that of normal people. It can also cause cerebrovascular diseases such as Alzheimer’s disease, depression and multiple sclerosis.
If a patient has homocysteine 75 μmol/L, it is recommended to visit the hospital as early as possible and follow the treatment prescribed by the doctor’s evaluation.